Curaleaf (CURLF) Stock Forecast & Price Target

$2.22 +0.02 (+0.91%)

(As of 11/15/2024 08:55 PM ET)

Curaleaf - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 3 Analyst Ratings

Sell
0

Hold
1

Buy
2

Based on 3 Wall Street analysts who have issued ratings for Curaleaf in the last 12 months, the stock has a consensus rating of "Buy." Out of the 3 analysts, 1 has given a hold rating, 1 has given a buy rating, and 1 has given a strong buy rating for CURLF.

Consensus Price Target

$6.25
181.53% Upside

According to the 3 analysts' twelve-month price targets for Curaleaf, the average price target is $6.25. The highest price target for CURLF is $6.25, while the lowest price target for CURLF is $6.25. The average price target represents a forecasted upside of 181.53% from the current price of $2.22.

Get the Latest News and Ratings for CURLF and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Curaleaf and its competitors.

CURLF Analyst Ratings Over Time

Type	Current Forecast 11/19/23 to 11/18/24	1 Month Ago 10/20/23 to 10/19/24	3 Months Ago 8/21/23 to 8/20/24	1 Year Ago 11/19/22 to 11/19/23
Strong Buy	1 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	1 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)	6 Buy rating(s)
Hold	1 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$6.25	$6.25	$6.25	$8.19
Forecasted Upside	181.53% Upside	100.32% Upside	101.61% Upside	125.55% Upside
Consensus Rating	Buy	Buy	Buy	Moderate Buy

Trump’s Victory Just Kicked the Door Open to a… (Ad)

This story is about a division that has been splitting America apart at the seams for the past three and a half years… Make no mistake, this division will definitely change YOUR financial future, for better or worse… That is why I’m sharing my post-election analysis of how this hidden division will impact your financial future…

And how Trump’s victory has just kicked-opened the door to a “Financial Miracle” for every American.

CURLF Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CURLF Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Curaleaf Stock vs. The Competition

Type	Curaleaf	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.80	2.50
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	181.53% Upside	28,621.01% Upside	9.87% Upside
News Sentiment Rating	Neutral News See Recent CURLF News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/10/2024	Roth Capital 3 of 5 stars	W. Kirk Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
11/7/2024	Cormark 3 of 5 stars	J. Pytlak Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Moderate Buy ➝ Hold
8/8/2024	Needham & Company LLC 3 of 5 stars		Reiterated Rating	Buy ➝ Buy	$6.25 ➝ $6.25	+96.00%
8/11/2023	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		C$3.50 ➝ C$3.00
7/5/2023	ATB Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform
7/4/2023	Atb Cap Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	F. Gomes Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
5/19/2023	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold
4/14/2023	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform	$8.50	+258.65%
4/14/2023	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy	$11.00 ➝ $8.00	+214.96%
12/30/2022	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight	$13.00 ➝ $12.00	+194.12%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 03:38 AM ET.

CURLF Forecast - Frequently Asked Questions

: According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for Curaleaf is $6.25, with a high forecast of $6.25 and a low forecast of $6.25.
: 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Curaleaf in the last twelve months. There is currently 1 hold rating, 1 buy rating and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CURLF shares.
: According to analysts, Curaleaf's stock has a predicted upside of 181.53% based on their 12-month stock forecasts.
: Over the previous 90 days, Curaleaf's stock had 1 upgrade and 1 downgrade by analysts.
: Curaleaf has been rated by research analysts at Cormark, and Roth Capital in the past 90 days.
: Analysts like Curaleaf more than other "medical" companies. The consensus rating for Curaleaf is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CURLF compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Trump’s Victory Just Kicked the Door Open to a… (Ad)

And how Trump’s victory has just kicked-opened the door to a “Financial Miracle” for every American.

This page (OTCMKTS:CURLF) was last updated on 11/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Curaleaf (CURLF) Stock Forecast & Price Target